IN8bio, Inc. received legal counsel opinion regarding its registered direct offering of up to $2.8 million in common stock through a Capital on Demand Sales Agreement with JonesTrading Institutional Services LLC, filed June 1, 2026. The offering expands the company's capital raising capabilities under its Form S-3 registration statement.